Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease

Eugene Hone, Florence Lim, Ian Martins

Research output: Chapter in Book/Conference paperChapter

Abstract

Lipidomics and genomics studies have made it very clear that lipids and their
metabolism are central in AD pathogenesis. This review has described many of the lipid-related changes that occur in AD, demonstrating the wide range of such changes and, in some cases, listing potential therapeutic treatments. Reducing the risk of AD will involve dietary changes and healthy lifestyles that can reduce the risk of dyslipidaemia, insulin resistance, type 2 diabetes, cardiovascular disease, and chronic inflammation, which are all known risk factors for AD. Despite the many studies on the influence of the APOE 휀4 allele on Aβ aggregation, binding, and clearance, the overall pathological effect of this allele is still not known. Further studies will consolidate these
findings and hopefully clarify which changes in lipid metabolism are most relevant in AD pathogenesis. It is hoped this will pave the way towards effective treatments, whilst highlighting the importance of preventing dyslipidaemia.
Original languageEnglish
Title of host publicationNeurodegeneration and Alzheimer's Disease
Place of PublicationLondon
PublisherJohn Wiley & Sons
Chapter7
Pages189-231
Edition1
ISBN (Print)9781119356783
Publication statusPublished - 1 May 2019

Fingerprint

Apolipoproteins E
Dyslipidemias
Lipid Metabolism
Alzheimer Disease
Fats
Alleles
Lipids
Genomics
Type 2 Diabetes Mellitus
Insulin Resistance
Cardiovascular Diseases
Inflammation
Therapeutics
Healthy Lifestyle

Cite this

Hone, E., Lim, F., & Martins, I. (2019). Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease. In Neurodegeneration and Alzheimer's Disease (1 ed., pp. 189-231). London: John Wiley & Sons.
Hone, Eugene ; Lim, Florence ; Martins, Ian. / Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease. Neurodegeneration and Alzheimer's Disease. 1. ed. London : John Wiley & Sons, 2019. pp. 189-231
@inbook{c7d9d57b7aa644ad8c14641dbe7fb87a,
title = "Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease",
abstract = "Lipidomics and genomics studies have made it very clear that lipids and theirmetabolism are central in AD pathogenesis. This review has described many of the lipid-related changes that occur in AD, demonstrating the wide range of such changes and, in some cases, listing potential therapeutic treatments. Reducing the risk of AD will involve dietary changes and healthy lifestyles that can reduce the risk of dyslipidaemia, insulin resistance, type 2 diabetes, cardiovascular disease, and chronic inflammation, which are all known risk factors for AD. Despite the many studies on the influence of the APOE 휀4 allele on Aβ aggregation, binding, and clearance, the overall pathological effect of this allele is still not known. Further studies will consolidate thesefindings and hopefully clarify which changes in lipid metabolism are most relevant in AD pathogenesis. It is hoped this will pave the way towards effective treatments, whilst highlighting the importance of preventing dyslipidaemia.",
author = "Eugene Hone and Florence Lim and Ian Martins",
year = "2019",
month = "5",
day = "1",
language = "English",
isbn = "9781119356783",
pages = "189--231",
booktitle = "Neurodegeneration and Alzheimer's Disease",
publisher = "John Wiley & Sons",
address = "United States",
edition = "1",

}

Hone, E, Lim, F & Martins, I 2019, Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease. in Neurodegeneration and Alzheimer's Disease. 1 edn, John Wiley & Sons, London, pp. 189-231.

Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease. / Hone, Eugene; Lim, Florence; Martins, Ian.

Neurodegeneration and Alzheimer's Disease. 1. ed. London : John Wiley & Sons, 2019. p. 189-231.

Research output: Chapter in Book/Conference paperChapter

TY - CHAP

T1 - Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease

AU - Hone, Eugene

AU - Lim, Florence

AU - Martins, Ian

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Lipidomics and genomics studies have made it very clear that lipids and theirmetabolism are central in AD pathogenesis. This review has described many of the lipid-related changes that occur in AD, demonstrating the wide range of such changes and, in some cases, listing potential therapeutic treatments. Reducing the risk of AD will involve dietary changes and healthy lifestyles that can reduce the risk of dyslipidaemia, insulin resistance, type 2 diabetes, cardiovascular disease, and chronic inflammation, which are all known risk factors for AD. Despite the many studies on the influence of the APOE 휀4 allele on Aβ aggregation, binding, and clearance, the overall pathological effect of this allele is still not known. Further studies will consolidate thesefindings and hopefully clarify which changes in lipid metabolism are most relevant in AD pathogenesis. It is hoped this will pave the way towards effective treatments, whilst highlighting the importance of preventing dyslipidaemia.

AB - Lipidomics and genomics studies have made it very clear that lipids and theirmetabolism are central in AD pathogenesis. This review has described many of the lipid-related changes that occur in AD, demonstrating the wide range of such changes and, in some cases, listing potential therapeutic treatments. Reducing the risk of AD will involve dietary changes and healthy lifestyles that can reduce the risk of dyslipidaemia, insulin resistance, type 2 diabetes, cardiovascular disease, and chronic inflammation, which are all known risk factors for AD. Despite the many studies on the influence of the APOE 휀4 allele on Aβ aggregation, binding, and clearance, the overall pathological effect of this allele is still not known. Further studies will consolidate thesefindings and hopefully clarify which changes in lipid metabolism are most relevant in AD pathogenesis. It is hoped this will pave the way towards effective treatments, whilst highlighting the importance of preventing dyslipidaemia.

M3 - Chapter

SN - 9781119356783

SP - 189

EP - 231

BT - Neurodegeneration and Alzheimer's Disease

PB - John Wiley & Sons

CY - London

ER -

Hone E, Lim F, Martins I. Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease. In Neurodegeneration and Alzheimer's Disease. 1 ed. London: John Wiley & Sons. 2019. p. 189-231